Institute for International Research

Know how to achieve

Main menu

My IBC

Login form

Sign Up

Preclinical Scale Bioprocessing

CSS

Event Information

Alternate Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

Strategies to Improve the Speed, Quality and Cost of Early Bioprocess Development

November 01 - 03, 2010 · Hyatt Harborside Boston · Boston, MA

Document Title

Speakers

Speakers

Distinguished Faculty

Mauricio Barraza, Ph.D., Acceleron Pharma

Paul Bezy, Genentech, Inc.

Hao Chen, Ph.D., Merck & Co., Inc.

Greg Conley, Ph.D., Dyax Corporation

Philippe de Vilmorin, Ph.D., Biogen Idec, Inc.

Semsi Ensari, Ph.D., Ambrx, Inc.

Mary Hoffee, Ph.D., Biogen Idec, Inc.

Chi Ting Huang, Ph.D., Acceleron Pharma

Bernie Huyghe, Ph.D., RAC, Pfizer

Thomas Strandet Jepsen, Novozymes A/S, Denmark

Rajesh Krishnamurthy, Ph.D., ImmunoGen, Inc.

Rajesh Krishnan, Ph.D., Merck & Co., Inc.

Steven Lang, Ph.D., MBA, Centocor R&D

Feng Li, Ph.D., Genentech, Inc.

Stewart McNaul, Diosynth Biotechnology

Deborah Meshulam, Ph.D., ImmunoGen, Inc.

Wenjun (David) Mo, Ph.D., MedImmune, Inc.

Anne O' Donnell, EMD Serono Biotech Center, Inc.

John O’Grady, MS, PhaseBio Pharmaceuticals, Inc.

Jonathan Romero, Ph.D., Biogen Idec, Inc.

Rebecca Sendak, Ph.D., Genzyme Corporation

A. Mark Trotter, Ph.D., Trotter Biotech Solutions

Paul Varley, Ph.D., MedImmune, United Kingdom

Malini Viswanathan, Ph.D., Dyax Corporation

Sue Walker, Millipore Corporation

David W. Wood, Ph.D., Ohio State University

Kevin Zen, Ph.D., Allergan

courses banner

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group

Powered by Interactive Agency Janmedia Interactive, Inc.